Hypothalamic neuropeptide release after experimental subarachnoid hemorrhage: In vivo microdialysis study

Acta Neurologica Scandinavica

Volumn 109, Issue 5, 2004, Pages 361-368

  Kleindienst, A ^a,b   Hildebrandt, G ^c   Kroemer, S A ^d   Franke, G ^a   Gaab, M R ^a   Landgraf, R ^d  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Neurosurgical Department   (Switzerland)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Experimental subarachnoid hemorrhage; Microdialysis; Oxytocin; Paraventricular nucleus; Supraoptic nucleus; Vasopressin

Indexed keywords

ARGIPRESSIN; NEUROPEPTIDE; OXYTOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HYPOTHALAMUS; IN VIVO STUDY; MALE; MICRODIALYSIS; NEUROSECRETION; NONHUMAN; PROTEIN SECRETION; RAT; SUBARACHNOID HEMORRHAGE;

ANIMALS; ARGININE VASOPRESSIN; HYPOTHALAMUS; MALE; NEUROPEPTIDES; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, WISTAR; SUBARACHNOID HEMORRHAGE; SUPRAOPTIC NUCLEUS;

EID: 2342534378     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-0404.2003.00245.x     Document Type: Article

References (37)

1. GROSS P, WEHRLE R, BÜSSEMAKER E. Hyponatremia: pathophysiology, differential diagnosis and new aspects of treatment. Clin Nephrol 1996;46:273-6.
2. LASZLO FA, VARGA C, DOCZI T. Cerebral edema after subarachnoid hemorrhage. Pathogenetic significance of vasopressin. Acta Neurochir 1995;133:122-33.
3. DIRINGER MN, WU KC, VERBALIS JG, HANLEY DF. Hypervolemic therapy prevents volume contraction but not hypovolemia following subarachnoid hemorrhage. Ann Neurol 1992;31:543-50.
4. BERENDES E, WALTER M, CULLEN R et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid hemorrhage. Lancet 1997;349:245-9.
5. ISOTANI E, SUZUKI R, TOMITA K et al. Alterations in plasma concentrations of natriuretic peptides and antidiuretic hormone after subarachnoid hemorrhage. Stroke 1994;25: 2198-203.
6. HATTON GI. Emerging concepts of structure-function dynamics in adult brain: the hypothalamo-neurohypophysial system. Prog Neurobiol 1990;34:437-504.
7. LANDGRAF R. Intracerebrally released vasopressin and oxytocin: measurement, mechanisms and behavioural consequences. J Neuroendocrinol 1995;7:243-53.
8. +? Brain Res 1992; 576:231-4.
9. JOLKKONEN J, TUOMISTO L, VAN WISMERSMA GREIDANUS TB, LAARA E, RIEKKINEN P. Effects of osmotic stimuli on vasopressin levels in the CSF of rats. Peptides 1988; 9(Suppl. 1):109-11.
10. MATHER HM, ANG V, JENKINS JS. Vasopressin in plasma and CSF of patients with subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry 1981;44:216-9.
11. DELGADO TB, ARBAB MA, WARBERG J, SVENDGAARD NA. The role of vasopressin in acute cerebral vasospasm. Effect on spasm of a vasopressin antagonist or vasopressin antiserum. J Neurosurg 1988;68:266-73.
12. DOCZI T, JOO F, SZERDAHELYI P, BODOSI M. Regulation of brain water and electrolyte contents: the opposite actions of central vasopressin and atrial natriuretic factor. Acta Neurochir Suppl 1988;43:186-8.
13. MEGYESI JF, VOLLRATH B, COOK DA, FINDLAY JM. In vivo model of cerebral vasospasm: a review. Neurosurgery 2000;46:448-61.
14. PAXINOS G, WATSON C, eds. The rat brain in stereotactic coordinates, 2nd Edition. San Diego: Academic Press Inc., 1996.
15. LANDGRAF R, KUBOTA M, HOLSBOER F, WOTJAK CT. Release of vasopressin and oxytocin within the brain and into blood: microdialysis and anti-sense targeting. In: SAITO T, KUROKAWA K, YOSHIDA S, eds. Neurohypophysis: recent progress of vasopressin and oxytocin research. Amsterdam: Elsevier, 1995;243-56.
16. KUROKAWA Y, UEDE T, ISHIGURO M et al. Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm. Surg Neurol 1996;46:500-8.
17. WOTJAK CT, GANSTER J, KOHL G et al. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons. Neuroscience 1998;85:1209-22.
18. HONDA Y, MINATO H, FUJITANI B, MASUDA Y, HOSOKI K. Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats. Methods Find Exp Clin Pharmacol 1997;19:699-70.
19. 2+ current in guinea pig ventricular myocytes. Pharmacology 1999;59:21-33.
20. RICKELS E, ZUMKELLER M. Vasospasm after experimentally induced subarachnoid hemorrhage and treatment with nimodipine. Neurochirurgia 1992;35:99-102.
21. HEINEMANN A, WACHTER CH, FICKERT P, TRAUNER M, STAUBER RE. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats. Hepatology 1998;28:646-54.
22. LANDGRAF R, LUDWIG M. Vasopressin release within the supraoptic and paraventricular nuclei of the rat brain: osmotic stimulation via microdialysis. Brain Res 1991; 558:191-6.
23. LUDWIG M, HORN T, CALLAHAN MF, GROSCHE A, MORRIS M, LANDGRAF R. Osmotic stimulation of the supraoptic nucleus: central and peripheral vasopressin release and blood pressure. Am J Physiol 1994;266:E351-6.
24. OTA M, CROFTON JT, SHARE L. Hemorrhage-induced vasopressin release in the paraventricular nucleus measured by in vivo microdialysis. Brain Res 1994;658:49-54.
25. DOCZI T, JOO F, ADAM G, BOZOKY B, SZERDAHELYI P. Blood brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model. Neurosurgery 1986;18:733-9.
26. BOURQUE CW. Osmoregulation of vasopressin neurons: a synergy of intrinsic and synaptic processes. Prog Brain Res 1998;119:59-76.
27. NELSON PB, SEIF S, GUTAI J, ROBINSON AG. Hyponatriemia and natriuresis following subarachnoid hemorrhage. J Neurosurg 1984;60:233-7.
28. RAP ZM, CHWALBINSKA-MONETA J. Vasopressin concentration in blood during acute short-term intracranial hypertension in rats. Adv Neurol 1978;20:381-8.
29. KING MS, BAERTSCHI AJ. Ventral pontine catecholaminergic pathway mediates the vasopressin response to splanchnic osmostimulation in conscious rats. Brain Res 1992;580: 81-91.
30. SAWCHENKO PE, SWANSON LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res Rev 1982; 257:275-325.
31. SOLOMON RA, ANTUNES JL, CHEN RYZ, BLAND L, CHIEN S. Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model. Stroke 1985;16:58-64.
32. LIPINSKA S, TRACZYK WZ. Increase in vasopressin release into the hypophysial portal blood after superior cervical ganglion stimulation in rat. J Physiol Pharmacol 1997;48: 423-33.
33. ORLOWSKA-MAJDAK M, TRACZYK WZ. Vasopressin content in the third ventricle and the fluid perfusing cerebral ventricles in rats after the afferent vagus nerve fibres stimulation. J Physiol Pharmacol 1996;47:329-39.
34. NAKAGOMI T, KASSELL NF, SASAKI T et al. Time course of the blood-arterial wall barrier disruption following experimental subarachnoid hemorrhage. Acta Neurochir 1989; 98:176-83.
35. XIONG JJ, HATTON GI. Differential responses of oxytocin and vasopressin neurons to the osmotic and stressful components of hypertonic saline injections: a Fos protein double labeling study. Brain Res 1996;719:143-53.
36. HUANG W, LEE SL, SJÖQUIST M. Effects of neurohypophysial antagonists in postnephrectomy natriuresis in male rats. Kidney Int 1994;45:692-9.
37. STRICKER EM, SCHREIHOFER AM, VERBALIS JG. Sodium deprivation blunts hypovolemia-induced pituitary secretion of vasopressin and oxytocin in rats. Am J Physiol 1994; 267:R1336-41.